CRISPR Therapeutics Presents New Preclinical Data for CTX460â„¢ Demonstrating In Vivo Gene Correction of Alpha-1 Antitrypsin Deficiency (AATD) Utilizing Novel SyNTaseâ„¢ Editing Platform
CRISPR Therapeutics AG -Preclinical data presented at the European Society of Gene and Cell Therapy (ESGCT) highlight a…